Apolipoprotein B-editing enzyme, catalytic polypeptide-1 (APOBEC1) is a cytidine deaminase initially identified by its activity in converting a specific cytidine (C) to uridine (U) in apolipoprotein B (apoB) mRNA transcripts in the small intestine. Editing results in the translation of a truncated apoB isoform with distinct functions in lipid transport. To address the possibility that APOBEC1 edits additional mRNAs, we developed a transcriptome-wide comparative RNA sequencing (RNA-Seq) screen. We identified and validated 32 previously undescribed mRNA targets of APOBEC1 editing, all of which are located in AU-rich segments of transcript 3′ untranslated regions (3′ UTRs). Further analysis established several characteristic sequence features of editing targets, which were predictive for the identification of additional APOBEC1 substrates. The transcriptomics approach to RNA editing presented here dramatically expands the list of APOBEC1 mRNA editing targets and reveals a novel cellular mechanism for the modification of transcript 3′ UTRs.
Apolipoprotein B-editing enzyme, catalytic polypeptide-1 (APOBEC1) is a cytidine deaminase initially identified by its activity in converting a specific cytidine (C) to uridine (U) in apolipoprotein B (apoB) mRNA transcripts in the small intestine. Editing results in the translation of a truncated apoB isoform with distinct functions in lipid transport. To address the possibility that APOBEC1 edits additional mRNAs, we developed a transcriptome-wide comparative RNA sequencing (RNA-Seq) screen. We identified and validated 32 previously undescribed mRNA targets of APOBEC1 editing, all of which are located in AU-rich segments of transcript 3′ untranslated regions (3′ UTRs). Further analysis established several characteristic sequence features of editing targets, which were predictive for the identification of additional APOBEC1 substrates. The transcriptomics approach to RNA editing presented here dramatically expands the list of APOBEC1 mRNA editing targets and reveals a novel cellular mechanism for the modification of transcript 3′ UTRs.
RNA editing refers to processes in which the base sequence of polynucleotide RNA is modified at specific sites. RNA-editing events introduce molecular diversity to sequences 'hard coded' in genomic DNA and contribute to numerous and varied biological functions. A-to-I conversion in tRNA anticodons affects coding specificity (reviewed in ref. 1) . Editing of mitochondrial RNA occurs in many diverse species by various mechanisms 2 . Editing of mRNA can alter protein coding sequences (reviewed in ref. 3 ) and modulate gene expression [4] [5] [6] [7] . In higher eukaryotes, two enzyme families mediate mRNA editing: the adenosine deaminases acting on RNA (ADARs) convert adenosine to inosine, and the polynucleotide cytidine deaminases (AID-APOBEC enzyme family) convert cytidine to uridine.
The apolipoprotein B (apoB) transcript was the first mRNA-editing target identified in mammals 8, 9 . The apoB protein product exists as two isoforms, both important in lipid metabolism. The full-length isoform, apoB-100, is produced by the liver and forms the principal lipoprotein component of low-density lipoprotein particles. The shorter apoB-48 isoform is produced by the small intestine, in which it is essential for the formation of chylomicron lipoprotein particles and the absorption and transport of dietary lipid. Both isoforms of apoB originate from an identical primary transcript but are not regulated by differential splicing or post-translational processing. In the small intestine, the cytidine at position 6666 of the apoB mRNA is deaminated to uridine, thereby converting a glutamine codon (CAA) to a stop codon (UAA) 8, 9 . Upon translation, this results in production of the truncated apoB-48 protein. This site-specific mRNA modification is mediated by a multiprotein 'editosome' complex, the catalytic component of which is APOBEC1 (ref. 10 ).
The first member of the AID-APOBEC family of enzymes to be identified, APOBEC1 is a zinc-dependent cytidine deaminase 11 present only in mammals 12 . In vitro, purified APOBEC1 binds polynucleotide RNA 13 , with a preference for AU-rich sequences 14 . APOBEC1 associates with APOBEC1 complementation factor, an RNA-binding component of the editosome necessary for editing of apoB mRNA 15, 16 . This factor selectively binds an 11-nucleotide (11-nt) mooring sequence several bases downstream of the edited cytidine in apoB mRNA 15 . This sequence motif is required for the site-specific editing of the apoB transcript 17 and is necessary and sufficient to induce C-to-U conversion in AU-rich heterologous RNA in vitro 18 . Apobec1 −/− mice lack detectable editing of apoB mRNA in small intestine and have no apoB-48 in serum 19, 20 . Although hepatic overexpression of APOBEC1 is oncogenic in mice and rabbits 21 , at present apoB mRNA is the only known physiological editing target of APOBEC1 in healthy tissue.
The identification of novel RNA editing targets has proven challenging, in large part because of the technical difficulty in detecting singlenucleotide alterations over entire transcriptomes. The development of ultra-high-throughput sequencing technologies has provided powerful tools for more comprehensive investigation of RNA editing. One recent study used target capture and ultra-high-throughput sequencing to detect A-to-I editing in numerous computationally predicted RNA targets 22 . Whole-transcriptome RNA sequencing (RNA-Seq) represents another promising option for the broad characterization of RNA editing. Although RNA-Seq is frequently used for transcriptome mapping and quantification [23] [24] [25] , it has also been successfully applied to the analysis of single-nucleotide polymorphisms (SNPs) in expressed genes 26, 27 .
r e s o u r c e
We reasoned that, given sufficient transcript coverage and read depth, the single-nucleotide resolution of RNA-Seq could be used to identify candidate mRNA-editing sites throughout a transcriptome. Applying a novel comparative RNA-Seq screening approach to mouse small intestine enterocytes, we have identified and validated numerous previously unknown mRNA-editing targets of APOBEC1. Unlike the well-characterized site in the coding sequence of apoB mRNA, these newly recognized editing sites are located in the 3′ UTRs of diverse transcripts. These sites share several characteristic sequence features, including a downstream (3′) motif similar to the mooring sequence in apoB mRNA. Bioinformatics analysis based on these features predicted additional APOBEC1 editing targets, which we subsequently validated by standard sequencing techniques. Finally, many of the APOBEC1 editing sites identified here are located within transcript regions conserved in mammalian evolution, which may indicate functional importance. Our findings demonstrate the feasibility and utility of a novel transcriptomics approach to RNA-editing studies and reveal numerous additional mRNA targets of APOBEC1 editing, thereby suggesting functions for this enzyme beyond its previously characterized role.
RESULTS

A comparative RNA-Seq screen for mRNA-editing targets
To identify candidate mRNA-editing sites, we developed a comparative RNA-Seq screen that distinguishes single-nucleotide variations between two transcriptomes ( Fig. 1) . We isolated jejunal epithelial cells from the small intestines of C57BL/6 wild-type and congenic Apobec1 −/− mice for analysis ( Supplementary Fig. 1 ). RNA-Seq libraries were prepared from poly(A) + mRNA and subjected to ultra-high-throughput sequencing, generating 76,766,760 (wildtype) and 50,509,000 (Apobec1 −/− ) 36-nt reads. Reads were aligned to the mouse reference genome (mm9; NCBI 37.1), allowing up to two mismatches per sequence. As accurate mapping and individual base content of the sequences are critical to the identification of single-nucleotide variants associated with editing, we used only those reads with sufficient quality scores that mapped to unique sites in the genome for analysis (42, 770 ,803 and 28,877,750 reads for wildtype and Apobec1 −/− samples, respectively; Supplementary Table 1 ).
Although this stringent alignment policy probably resulted in reduced coverage of orthologous and repetitive transcript regions, it eliminated a potential source of false-positive hits from the incorrect mapping of mismatch-containing reads. Read coverage of transcripts at single-base resolution was extensive, particularly for genes expressed at moderate to high levels ( Supplementary Fig. 2) .
The strategy for detecting potential RNA-editing events involved the identification of sample-specific single-nucleotide mismatches in RNA-Seq reads relative to those in the reference sequence ( Fig. 1 and Supplementary Table 2 ). Because of APOBEC1's cytidinedeaminase activity, we used a modified SNP-calling algorithm to find sites within RefSeq exons at which the reference genome contained a cytidine and wild-type reads contained thymidines (or reference guanine and RNA-Seq read adenosines for negative-strand transcripts, in the genomic context). Those sites were then compared with Apobec1 −/− reads. If the corresponding position in Apobec1 −/− reads also contained the mismatch, the site was discarded as a likely genomic polymorphism or non-APOBEC1 modification. However, if the corresponding location in Apobec1 −/− reads matched the reference sequence, the site was selected for additional analysis (example, Supplementary Fig. 3 ). After filtering out those sites with insufficient read coverage (less than five reads for wild-type; less than three reads for Apobec1 −/− ) and/or mismatch probability scores ( Supplementary  Table 2 ), we were left with a set of 39 candidate APOBEC1 mRNAediting targets. When we ranked candidate targets by mismatch probability score (described in the Online Methods), the top hit was the well-characterized site in apoB mRNA, which served as an internal positive control for the screening method. This result confirmed that our sequencing methodology and analysis pipeline could successfully detect single-nucleotide editing events on a transcriptome scale.
Validation of candidate APOBEC1 mRNA-editing sites
To validate the potential editing events identified by our RNA-Seq screen, we used standard dideoxynucleotide Sanger sequencing to examine the sites in genomic DNA and RNA (cDNA) isolated from intestinal epithelium. We independently prepared all validation samples from different mice than those used for RNA-Seq libraries. Sanger sequencing results for several representative sites are presented here ( Fig. 2a-d) . We observed clear evidence of C-to-U(T) RNA editing at 33 of the 39 candidate sites. The overlapping cytidine and thymidine chromatogram peaks in wild-type cDNA were of varied intensity, which indicated differences in editing levels. At one site (chr3:73442586(−); Fig. 2d ), we observed additional editing at a cytidine adjacent to the location identified by the screen. To further validate APOBEC1-specific editing, we selected several sites for subcloning and additional Sanger sequencing. We observed C:T mismatches at candidate editing sites only in subclones derived from wild-type cDNA; none were present in wild-type genomic DNA, Apobec1 −/− genomic DNA or Apobec1 −/− cDNA ( Supplementary  Fig. 4a-e ). Additionally, we observed low-level 'hyperediting' of cytidine residues in close proximity to the primary editing site in a minority of subclones for several targets, including apoB ( Supplementary  Fig. 4f ). This phenomenon has been previously described for apoB mRNA and is of unknown functional significance [28] [29] [30] .
A list of validated APOBEC1 mRNA editing targets is in Supplementary Table 3 . Unlike the edited coding sequence of apoB mRNA, all of the newly identified APOBEC1 sites are located in 3′ UTRs. We used our RNA-Seq read data to estimate the editing level of each site ([number of T reads] / [number of C reads + number of T reads]). The apoB mRNA displayed the most pronounced editing (0.92), whereas the editing frequency of 3′ UTR sites ranged from 0.18 r e s o u r c e to 0.79 ( Fig. 2e) . Editing frequencies calculated from RNA-Seq reads were very similar to those determined by cDNA amplification, subcloning and Sanger sequencing (examples, Supplementary Fig. 4e ).
APOBEC1 mRNA-editing targets share characteristic features
Target recognition by RNA-editing enzymes is typically determined by the sequence and/or structural context of the edited base 31, 32 .
Although features that contribute to the editing of apoB mRNA have been previously characterized, it was unclear whether similar attributes would apply to the editing of 3′ UTR targets by APOBEC1.
To determine if the sites identified shared common features that might specify them for APOBEC1 editing, we examined the sequences around the target cytidines. APOBEC1 has RNA-binding activity with a preference for sequences rich in adenosine and uridine 13, 14 . The sequence region (101-nt) surrounding the apoB mRNA-editing site was also particularly AU rich (0.70 AU content). We determined the AU content of the 3′ UTRs edited by APOBEC1 (0.63) and found them to be significantly more AU rich than comparable sets of 3′ UTRs chosen at random (P < 0.0001; Fig. 3a ). We also found that within these AU-rich 3′ UTRs, the local regions (101 nt centered on the site) containing the editing sites were further enriched in adenosine and uridine bases (0.69; P = 0.0002; Fig. 3b,c) . These results are consistent with a model in which APOBEC1 targets require a high AU sequence context for efficient editing.
Beyond regional sequence content, other cytidine deaminases in the AID-APOBEC family exhibit strong preferences for specific bases immediately neighboring their editing targets 33 . Such preferences have not been described for APOBEC1, probably because of its perceived specificity for a single substrate. By aligning the 3′ UTR editing sites, we found that almost all of the edited cytidine bases were immediately flanked by adenosine or uridine bases at positions −1 and +1 relative to the editing site (P = 8 × 10 −5 ; Fig. 3d,e ). There were no apparent nucleotide preferences at positions −4, −3, −2 and +2, +3, +4 relative to the editing site.
DNA-and RNA-binding proteins often recognize and bind to sequence motifs in their molecular targets. To ascertain whether the APOBEC1 editing targets identified here share a common sequence element potentially important for editosome recognition, we used the multiple em for motif elicitation (MEME) algorithm 34 to analyze the sequence regions (101 nt centered on the target cytidine) surrounding the editing sites. MEME analysis revealed a significant 10-nt motif in regions adjacent to most (21 of 31) editing sites (log likelihood ratio of 157 and E value of 8.8 × 10 −1 , compared with 65 and 3 × 10 2 , respectively, for the shuffled-sequence control 'best' motif; Fig. 4a ). Next, we used the motif consensus sequence WRAUYANUAU to manually align the editing site-containing sequences (Fig. 4b) . We found close or exact consensus motif matches downstream of almost every editing site, with most (24 of 32) appearing 4-6 nt from the target cytidine. Of note, the consensus motif also matched the first 10-nt of the apoB mooring sequence, which is 5 nt downstream of its editing site 17, 35 . These results suggest that most of the 3′ UTR sites are edited by a mechanism similar to that used for editing the apoB transcript.
Predicted APOBEC1 targets are not edited in coding sequences
With the set of newly identified target sites and their characteristic sequence features described above, we had a refined list of criteria for sequences edited by APOBEC1. Drawing on our findings, we derived an APOBEC1 editing 'sequence pattern' consisting of a cytidine flanked on both sides by either adenosine or uridine and followed by an appropriately spaced mooring motif (WCWN 2-4 . 5a ). To evaluate the distribution of potential APOBEC1 editing targets throughout the transcriptome, we searched for this sequence pattern in all RefSeq exons. We found nearly 400 examples of this pattern in mouse mRNAs ( Fig. 5b and Supplementary  Table 4 ), 181 of which occurred in transcripts expressed in small intestine enterocytes (RNA-Seq analysis, reads per kilobase exon per million reads mapped greater than 1.0). Bypassing the comparative editing screen workflow, we directly examined the wild-type RNA-Seq read sequences at these sites for evidence of RNA editing ( Fig. 5c) . Of the 74 patterns located in 3′ UTRs with read coverage (three or more wildtype reads), we detected C:T mismatches indicative of editing at 32 sites. Of the 34 patterns present in coding exons covered by RNA-Seq reads, only the apoB site displayed evidence of editing. Additionally, we examined a subset of these sites (7 in coding sequences, 14 in 3′ UTR sequences) by Sanger sequencing, which confirmed C-to-U editing in 9 of the 3′ UTR sites but none of the coding sequence sites ( Fig. 5d-f ). Although we did not detect many of these sites in the RNA-Seq screen because of insufficient read coverage in the Apobec1 −/− library and/or relatively low editing frequencies, the APOBEC1 sequence pattern derived from the initially identified targets was clearly predictive of additional 3′ UTR-editing targets of APOBEC1. These results suggest that although the APOBEC1 sequence pattern supports editing at numerous sites in transcript 3′ UTRs, it is not targeted when present in coding sequences. The notable exception of apoB r e s o u r c e raises questions about the mechanism of APOBEC1 sequence recognition and localization as well as the role of editing in 3′ UTRs.
APOBEC1 editing occurs in conserved mRNA sequence regions
Functional elements within 3′ UTRs are more likely than other non-coding sequences to be conserved through evolution 36 . When inspecting the APOBEC1 editing sites, we observed that many seemed to occur within regions of considerable phylogenetic conservation (two examples are presented in Supplementary Fig. 5a,b) . To systematically assess the conservation of sequence regions containing APOBEC1 editing sites, we compared the conservation scores (phastCons scores for placental mammals 37 ) of 101-nt windows centered on the initially identified editing sites with those of random 101-nt windows within the same 3′ UTRs. As a set, the regions containing APOBEC1 editing sites were significantly more conserved (P = 0.01; Supplementary Fig. 5c ), which suggested that these sequences may be of functional importance. Together these results indicate that APOBEC1 edits many mRNA transcripts other than apoB in small intestine enterocytes in a sitespecific manner. To our knowledge, they provide the first reported examples of C-to-U mRNA editing in 3′ UTRs, a molecular mechanism that suggests additional roles for APOBEC1 beyond its function in apolipoprotein regulation.
DISCUSSION
Recent advances in ultra-high-throughput DNA sequencing technologies have redefined the scale at which transcriptomes can be studied. Early RNA-Seq experiments with yeast 23 , mouse tissues 24 and human cells 25 revealed numerous, previously unidentified genes, splicing events and transcript untranslated regions, demonstrating a level of transcriptome complexity not previously appreciated. Despite the massive scope of whole-transcriptome datasets, RNA-Seq also provides mRNA sequence information at single-nucleotide resolution.
Although such information can be used to examine 'expressed SNPs' 26, 27 , it also provides a powerful tool with which to study RNA editing in an unbiased manner, as described here.
As is the case for many RNA-editing enzymes, an edited target (apoB mRNA) of APOBEC1 was identified prior to discovery of the enzyme responsible. After the demonstration of C-to-U editing in apoB mRNA 8, 9 , numerous biochemical and genetic strategies were used to eventually trace back the activity to an unidentified molecule subsequently characterized as a cytidine deaminase: APOBEC1 (refs. 10, 11, 38, 39) . Despite extensive study of APOBEC1 sequence preferences, as well as the observation of edited neurofibromin 1 mRNA in tumor cells 40, 41 , physiological editing of mRNAs other than apoB by APOBEC1 has not been described. As studies examining limited sets of candidate transcripts have not revealed C-to-U alterations, APOBEC1 editing has been thought to be specific mainly for apoB mRNA.
The comparative RNA-Seq screen described here has allowed an unbiased and more comprehensive search for APOBEC1 editing targets. In addition to detecting the well-characterized editing site in apoB mRNA, we identified and validated 32 previously unknown APOBEC1 editing sites in the 3′ UTRs of diverse mRNA transcripts. This set of targets revealed several characteristic features of APOBEC1 editing sites, including a strong preference for adenosine and uridine bases immediately neighboring the edited cytidine and a 3′ mooring motif encompassing that previously described for apoB. Using these sequence features as a guide, we found that although similar patterns are present in coding and untranslated sequences throughout the transcriptome, APOBEC1 editing was constrained mainly to 3′ UTRs. Although they do not result in protein-coding changes, many of the editing sites identified here are located within evolutionarily conserved sequences, which may indicate functional relevance.
The localization of all the newly identified editing sites to transcript 3′ UTRs raises questions about the mechanism by which APOBEC1 edits the apoB coding sequence. Despite the presence of motifs consistent with APOBEC1 editing within coding and untranslated sequences throughout the transcriptome, our RNA-Seq data suggest that APOBEC1 acts only on those targets located in 3′ UTRs. Thus, in terms of APOBEC1 targeting, editing of the coding sequence of apoB seems to be the exception rather than the rule. It is interesting to note that after apoB mRNA is edited by APOBEC1, the downstream coding r e s o u r c e sequence becomes a 3′ UTR. This may represent an important link in the relationship of this well-known mRNA target with the 3′ UTR editing sites.
The distribution of APOBEC1 sites in coding sequence (apoB) as well as transcript 3′ UTRs is reminiscent of editing by ADARs, another family of RNA deaminases. ADARs deaminate adenosine to inosine in numerous RNAs at diverse tissue sites 3 . Much like C-to-U deamination in apoB, some initial examples of A-to-I modification were observed in tissue-specific transcripts (such as glutamate receptor mRNAs in the brain), which have protein-encoding sequences modified as a consequence of editing 42 . Similar coding changes have been observed in several other neuronal transcripts (reviewed in ref. 32) . Additional A-to-I editing events have been found to affect protein sequence by initiating alternative RNAsplicing events (reviewed in ref. 3) . However, recent bioinformatic analyses 43 and ultra-high-throughput sequencing experiments 22 have demonstrated that most A-to-I RNA editing occurs in non-coding RNA sequences, especially transcript 3′ UTRs. As is the case for APOBEC1 ( Fig. 2e) , ADAR editing varies in efficiency for different target transcripts 22 . Although the functional consequences of most of these editing events remain largely unknown, a small number of targets have been examined in some detail. In these cases, A-to-I editing in 3′ UTR sequences has been shown to induce nuclear retention of transcripts 7 , to target mRNA cleavage 44 and to modify microRNA (miRNA) target sites, which could potentially modulate gene expression 45, 46 . Although some remain controversial, these findings provide illustrative examples of how nucleotide changes in non-coding sequence can affect genetic output.
Might the editing of 3′ UTRs by APOBEC1 have similar functional consequences? On the basis of the sequence context of many sites described here, we can speculate about several possible functional outcomes for APOBEC1 editing. First, 3′ UTRs contain sequence and structural motifs recognized by RNA-binding proteins. APOBEC1 editing events in four transcript 3′ UTRs are predicted to generate new AU-rich elements (AUUUA pentamers), which could contribute to transcript instability via their interaction with various RNAbinding proteins (reviewed in ref. 47) . Second, 3′ UTRs represent the principal targets of transcript regulation by miRNAs. More than 35% of APOBEC1 editing sites are located within sequences that match the seed targets of known miRNAs ( Supplementary Table 5 ). Cytidine deamination at these sites would modify target sequences and potentially abolish miRNA binding. Conversely, APOBEC1 editing could introduce new miRNA seed target sequences or shift existing targets to sequences that recruit different miRNAs. It should be noted that miRNA targeting is enhanced within regions rich in adenosine and uridine nucleotides 48 , a prominent feature of APOBEC1 editing sites (Fig. 3a-c) . Finally, APOBEC1-mediated alterations in 3′ UTRs could affect additional post-transcriptional processes, including transcript polyadenylation, subcellular localization, and translational efficiency.
Without flexible mouse enterocyte models that can be manipulated in vitro, direct experimental evidence for the functional and physiological relevance of these editing events would require the detection of altered translational outcomes in APOBEC1-expressing enterocytes in vivo. Furthermore, as Apobec1 −/− enterocytes accumulate triacylglycerol lipids because of apoB-related deficiencies in chylomicron formation 49 , direct regulatory effects due to the absence of 3′ UTR editing of various target transcripts are difficult to evaluate, as they may be obscured by the indirect cellular effects of the absence of apoB editing on lipid metabolism. For these technical reasons, experimental evidence for the biological effects of APOBEC1 editing has remained elusive. However, the localization of many APOBEC1 edit sites within regions conserved in mammalian evolution (Supplementary Fig. 5 ) suggests functional relevance.
Although it is often considered an intestine-specific protein, APOBEC1 is expressed at diverse tissue sites in numerous mammals 50, 51 (B.R.R. and F.N.P., unpublished data). As many of these tissues do not express apoB, the function of APOBEC1 and its editing activity has been unclear. The identification of multiple previously unknown physiological editing substrates for APOBEC1 raises the possibility of functionally significant mRNA editing in these tissues. Thus, our results suggest additional functions for APOBEC1 beyond its characterized role in lipid transport, both in small intestine enterocytes as well as other cell types.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
